Crystallographic fragment screen of Enterovirus D68 3C protease and iterative design of lead-like compounds using structure-guided expansions

Author:

Lithgo Ryan M.ORCID,Tomlinson Charles W.E.ORCID,Fairhead MichaelORCID,Winokan Max,Thompson WarrenORCID,Wild ConorORCID,Aschenbrenner Jasmin CaraORCID,Balcomb Blake H.ORCID,Marples Peter G.ORCID,Chandran Anu VORCID,Golding MathewORCID,Koekemoer LizbeORCID,Williams Eleanor P.ORCID,Wang SiYl,Ni XiaominORCID,MacLean ElizabethORCID,Giroud CharlineORCID,Zarganes-Tzitzikas Tryfon,Godoy Andre SchutzerORCID,Xavier Mary-AnnORCID,Walsh MartinORCID,Fearon DarenORCID,von Delft FrankORCID

Abstract

AbstractThe development of effective broad-spectrum antivirals forms an important part of preparing for future pandemics. One cause for concern is the currently emerging pathogenEnterovirus D68(EV-D68) which primarily spreads through respiratory routes causing mostly mild to severe respiratory illness but, in severe cases, acute flaccid myelitis. The 3C protease of EV-D68 (3Cpro) is a potential target for the development of antiviral drugs due to its essential role in the viral life cycle and high sequence conservation amongst family members. In this study, we describe the identification of fragments which bind to3Cprousing crystallographic screening and the expansion of these into more lead-like compounds. The hits revealed interesting directions for hit-to-lead progression, specifically the importance of the pocket occupied by the conserved glutamine sidechain of the substrates and the interactions formed. Additionally, two pockets could be joined by not following the backbone of the native substrates, thus circumventing the screening issues arising from the flexibility of the catalytic triad. These observations of the novel binding modes of the chemical matter found by this screen can help shape future drug design campaigns against 3C proteases.

Publisher

Cold Spring Harbor Laboratory

Reference56 articles.

1. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/

2. AI-driven Structure-enabled Antiviral Platform (ASAP). (2024). https://asapdiscovery.org/

3. Antiviral drug discovery: preparing for the next pandemic

4. Enterovirus D68 in Hospitalized Children, Barcelona, Spain, 2014–2021

5. Exploring protein hotspots by optimized fragment pharmacophores

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3